| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.083 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.094 | 0.6 |